Clinical trial
Use of Thalidomide in Chronic Uveitis
NCT00314665 · University of Cincinnati, Other · Terminated
Key facts
| NCT number | NCT00314665 |
|---|---|
| Title | Use of Thalidomide in Chronic Uveitis |
| Official title | Use of Thalidomide in Chronic Uveitis |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | Celgene Corporation Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Uveitis |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 15 |
| Start date | Jan 1, 2004 |
| Completion | Aug 1, 2006 |
| First posted | Apr 14, 2006 |
| Last update posted | Dec 6, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: